| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Beyond mice: Emerging and transdisciplinary models for the study of early-onset myopathies
|
Jagla, Krzysztof
|
|
2017
|
64 |
C |
p. 171-180
|
artikel
|
| 2 |
Ca2+ handling abnormalities in early-onset muscle diseases: Novel concepts and perspectives
|
Treves, Susan
|
|
2017
|
64 |
C |
p. 201-212
|
artikel
|
| 3 |
Cancer heterogeneity and imaging
|
O’Connor, James P.B.
|
|
2017
|
64 |
C |
p. 48-57
|
artikel
|
| 4 |
Cancer heterogeneity determined by functional proteomics
|
Szász, A. Marcell
|
|
2017
|
64 |
C |
p. 132-142
|
artikel
|
| 5 |
Clonal cooperativity in heterogenous cancers
|
Zhou, Hengbo
|
|
2017
|
64 |
C |
p. 79-89
|
artikel
|
| 6 |
Colorectal cancer heterogeneity and targeted therapy: Clinical implications, challenges and solutions for treatment resistance
|
Zhai, Zhenhua
|
|
2017
|
64 |
C |
p. 107-115
|
artikel
|
| 7 |
Correlation between mucin biology and tumor heterogeneity in lung cancer
|
Xu, Menglin
|
|
2017
|
64 |
C |
p. 73-78
|
artikel
|
| 8 |
Current and future therapeutic approaches to the congenital myopathies
|
Jungbluth, Heinz
|
|
2017
|
64 |
C |
p. 191-200
|
artikel
|
| 9 |
Defining, distinguishing and detecting the contribution of heterogeneous methylation to cancer heterogeneity
|
Pisanic II, Thomas R.
|
|
2017
|
64 |
C |
p. 5-17
|
artikel
|
| 10 |
Detection of single cell heterogeneity in cancer
|
Qian, Mengjia
|
|
2017
|
64 |
C |
p. 143-149
|
artikel
|
| 11 |
Drug resistance in ALK-positiveNon-small cell lungcancer patients
|
Qian, Mengjia
|
|
2017
|
64 |
C |
p. 150-157
|
artikel
|
| 12 |
Early-onset myopathies: Entering a new age
|
Ferreiro, Ana
|
|
2017
|
64 |
C |
p. 158-159
|
artikel
|
| 13 |
Editorial Board/Publication Information
|
|
|
2017
|
64 |
C |
p. CO2
|
artikel
|
| 14 |
Fibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications
|
Serrano, Antonio L.
|
|
2017
|
64 |
C |
p. 181-190
|
artikel
|
| 15 |
Gene heterogeneity in metastasis of colorectal cancer to the lung
|
Hou, Jiayun
|
|
2017
|
64 |
C |
p. 58-64
|
artikel
|
| 16 |
Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors
|
Wu, Duojiao
|
|
2017
|
64 |
C |
p. 125-131
|
artikel
|
| 17 |
Molecular heterogeneity in breast cancer: State of the science and implications for patient care
|
Ellsworth, Rachel E.
|
|
2017
|
64 |
C |
p. 65-72
|
artikel
|
| 18 |
Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies
|
Moulin, Maryline
|
|
2017
|
64 |
C |
p. 213-223
|
artikel
|
| 19 |
New era in genetics of early-onset muscle disease: Breakthroughs and challenges
|
Ravenscroft, Gianina
|
|
2017
|
64 |
C |
p. 160-170
|
artikel
|
| 20 |
Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer
|
Hsieh, James J.
|
|
2017
|
64 |
C |
p. 98-106
|
artikel
|
| 21 |
Role of epigenetics in lung cancer heterogeneity and clinical implication
|
Dong, Nian
|
|
2017
|
64 |
C |
p. 18-25
|
artikel
|
| 22 |
Role of osteopontin in lung cancer evolution and heterogeneity
|
Shi, Lin
|
|
2017
|
64 |
C |
p. 40-47
|
artikel
|
| 23 |
Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer
|
Wang, Lingyan
|
|
2017
|
64 |
C |
p. 90-97
|
artikel
|
| 24 |
Systems heterogeneity: An integrative way to understand cancer heterogeneity
|
Wang, Diane Catherine
|
|
2017
|
64 |
C |
p. 1-4
|
artikel
|
| 25 |
Telocytes heterogeneity: From cellular morphology to functional evidence
|
Cretoiu, Dragos
|
|
2017
|
64 |
C |
p. 26-39
|
artikel
|
| 26 |
The impact of heterogeneity in phosphoinositide 3-kinase pathway in human cancer and possible therapeutic treatments
|
Wang, William
|
|
2017
|
64 |
C |
p. 116-124
|
artikel
|
Tijdschrift beschrijving